These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6749591)

  • 21. Differentiation of host-mediated antitumor agents from mitotic posons by the antitumor foot-pad reaction in Ehrlich carcinoma-ddY mouse system.
    Abe S; Ohkuma M; Yamazaki M; Mizuno D
    Gan; 1976 Oct; 67(5):685-92. PubMed ID: 1017584
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Modulation of the anti-tumor effect of BRM under various nutritional or endocrine conditions].
    Akimoto M; Nishihira T; Kasai M
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1270-6. PubMed ID: 3729450
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antitumor activity of Klebsiella 03 lipopolysaccharide in mice.
    Miyamoto K; Koshiura R; Hasegawa T; Kato N
    Jpn J Pharmacol; 1984 Sep; 36(1):51-7. PubMed ID: 6503048
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of forphenicinol, a small molecular immunomodifier, in combination with cyclophosphamide on growth of and immunity to syngeneic murine tumors.
    Nitta K; Tanaka T; Takeuchi M
    Cancer Treat Rep; 1985 Mar; 69(3):285-91. PubMed ID: 3978657
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prevention of 5-FU induced toxicity in C3 H/HE mice with interferon or with interferon inducers (poly 1: C, OK-432, Lentinan)].
    Akimoto M; Ueki H; Nakajima Y; Matano S; Ewasaki H; Abe R; Kasai M
    Gan To Kagaku Ryoho; 1984 Jul; 11(7):1462-7. PubMed ID: 6204597
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preclinical evaluation of lentinan in animal models.
    Chihara G
    Adv Exp Med Biol; 1983; 166():189-97. PubMed ID: 6606302
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Passive immunotherapy of established tumors with syngeneic antitumor serum in combination with immunopotentiators.
    Shinoda H; Yamazaki M; Mizuno D
    Gan; 1977 Oct; 68(5):567-71. PubMed ID: 590681
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Synergistic action of lentinan (LNT) with endocrine therapy of breast cancer in rats and humans].
    Kosaka A; Kuzuoka M; Yamafuji K; Imaizumi A; Hattori Y; Yamashita A
    Gan To Kagaku Ryoho; 1987 Feb; 14(2):516-22. PubMed ID: 3101609
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Modulation of anticancer effects of immunochemotherapeutic agents in various nutritional environments].
    Akimoto M; Nishihira T; Mori S
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):827-33. PubMed ID: 3260467
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Age-dependent anti-tumor activity of lentinan in mice].
    Shiio T; Yoshihama T; Tsuchiya Y; Yugari Y
    Gan To Kagaku Ryoho; 1987 Jul; 14(7):2300-4. PubMed ID: 3606149
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effects of protein calorie intake on immuno- and chemotherapy].
    Akimoto M; Abe R; Kasai M
    Gan To Kagaku Ryoho; 1982 Aug; 9(8):1387-93. PubMed ID: 6820915
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Humoral Anti-Ehrlich carcinoma factor found in mice with tumor resistance acquired by intradermal lipopolysaccharide administration.
    Yamazaki M; Ohkuma S; Mizuno D
    Gan; 1974 Aug; 65(4):337-44. PubMed ID: 4609824
    [No Abstract]   [Full Text] [Related]  

  • 33. Antitumor activity of 2-keto-3-deoxyoctonate-free lipopolysaccharide of Vibrio anguillarum in mice.
    Shimizu T; Itoh Y; Mifuchi I; Iguchi T; Kondo S; Hisatsune K
    Gan; 1983 Apr; 74(2):279-84. PubMed ID: 6862149
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Preparation and anti-tumor activity of monoclonal antibody against ascitic mammary tumor MM46 cells].
    Takahashi T; Seto M; Hara T
    Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt 2):544-50. PubMed ID: 6192760
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [In vitro and in vivo antitumor activity of monoclonal anti-MM46 antibody-ricin A chain conjugate].
    Takahashi T; Seto M; Hara T
    Gan To Kagaku Ryoho; 1983 Aug; 10(8):1894-1900. PubMed ID: 6882010
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Different local therapeutic effects of various polysaccharides on MH134 hepatoma in mice and its relation to inflammation induced by the polysaccharides.
    Abe S; Takahashi K; Tsubouchi J; Aida K; Yamazaki M; Mizuno D
    Gan; 1984 May; 75(5):459-65. PubMed ID: 6745566
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endogenous tumor necrosis factor induction with Bordetella pertussis vaccine as a triggering agent and its therapeutic effect on MM46 carcinoma-bearing mice.
    Minagawa H; Kakamu Y; Yoshida H; Tomita F; Oshima H; Mizuno D
    Jpn J Cancer Res; 1988 Mar; 79(3):384-9. PubMed ID: 3131286
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Scanning electron microscopic observation of mouse ascitic carcinoma cells after intraperitoneal administration of lentinan].
    Kurokawa T; Tamakuma S
    Nihon Gan Chiryo Gakkai Shi; 1990 Dec; 25(12):2822-7. PubMed ID: 2074392
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Typing of immunomodulators in terms of their effects on the electrophoretic pattern of serum proteins and antitumor combination therapy based on this typing.
    Yoshioka O; Abe S; Masuko Y; Mizuno D
    Gan; 1981 Aug; 72(4):471-8. PubMed ID: 7308662
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antitumor and metastasis-inhibitory activities of lentinan as an immunomodulator: an overview.
    Chihara G; Hamuro J; Maeda YY; Shiio T; Suga T; Takasuka N; Sasaki T
    Cancer Detect Prev Suppl; 1987; 1():423-43. PubMed ID: 3319150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.